Hepatitis B reactivation in a chronic hepatitis C patient treated with ledipasvir and sofosbuvir: A case report

Clinics and Research in Hepatology and Gastroenterology

Volumn 41, Issue 2, 2017, Pages e17-e18

  Ou, Pengcheng ^a   Fang, Zhixiong ^b   Chen, Jun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Xiangtan Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; LEDIPASVIR; PEGINTERFERON ALPHA2A; RIBAVIRIN; SOFOSBUVIR; VIRUS DNA; VIRUS RNA; ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL DISTENSION; ADULT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CHRONIC HEPATITIS C; CHRONOPHARMACOLOGY; COMBINATION DRUG THERAPY; DECREASED APPETITE; DOSE RESPONSE; FATIGUE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS SUBTYPE 1B; HUMAN; LIVER DYSFUNCTION; MALE; MIDDLE AGED; MIXED INFECTION; TREATMENT DURATION; TREATMENT RESPONSE; URINE COLOR; VIRUS LOAD; VIRUS REACTIVATION; WEAKNESS; COMPLICATION; RECURRENT DISEASE; TIME FACTOR; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; BENZIMIDAZOLES; DRUG THERAPY, COMBINATION; FLUORENES; HEPATITIS B; HEPATITIS C, CHRONIC; HUMANS; RECURRENCE; SOFOSBUVIR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84994520390     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2016.08.001     Document Type: Article

References (5)

1. [1] Zhu, W., Wu, C., Deng, W., Pei, R., Wang, Y., Cao, L., et al. Inhibition of the HCV core protein on the immune response to HBV surface antigen and on HBV gene expression and replication in vivo. Plos One, 7, 2012, e45146.
2. [2] Chen, S.Y., Kao, C.F., Chen, C.M., Shih, C.M., Hsu, M.J., Chao, C.H., et al. Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. J Biol Chem 278:1 (2003), 591–607.
3. [3] Collins, J.M., Raphael, K.L., Terry, C., Cartwright, E.J., Pillai, A., Anania, F.A., et al. Virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir. Clin Infect Dis 61:8 (2015), 1304–1306.
4. [4] Takayama, H., Sato, T., Ikeda, F., Fujiki, S., Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection. Hepatol Res 46:5 (2016), 489–491.
5. [5] Ende, A.R., Kim, N.H., Yeh, M.M., Harper, J., Landis, C.S., Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report. J Med Case Rep, 28(9), 2015, 164.